MooreKuehn.jpg
Moore Kuehn Encourages CBMG, CLCT, TNAV, and ARA Investors to Contact Law Firm
December 29, 2020 11:03 ET | Moore Kuehn
NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether...
MooreKuehn-1.png
Moore Kuehn Encourages CGIX, CXO, CBMG, and RESI Investors to Contact Law Firm
November 12, 2020 12:25 ET | Moore Kuehn
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether...
PDF to PNG Logo.png
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigation of Cellular Biomedicine Group, Inc. Buyout
October 26, 2020 17:17 ET | Rigrodsky & Long, P.A.
WILMINGTON, Del., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Cellular Biomedicine Group, Inc. (“CBMG”) (NASDAQ GS: CBMG) regarding possible...
Shareholders Foundation
June 22 Deadline in Lawsuit for Investors in Cellular Biomedicine Group Inc (NASDAQ:CBMG) Shares Announced by Shareholders Foundation
June 01, 2015 09:55 ET | Shareholders Foundation, Inc.
SAN DIEGO, June 01, 2015 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of shares of Cellular Biomedicine Group Inc...